Late outcome of percutaneous mitral commissurotomy: Randomized comparison of Inoue versus double-balloon technique

Sahmin Lee1, Duk-Hyun Kang1, Dae-Hee Kim1

  • 1Divisions of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, Republic of Korea.

American Heart Journal
|December 11, 2017
PubMed
Abstract

Insights

Percutaneous mitral commissurotomy (PMC) techniques using Inoue and double-balloon show similar long-term outcomes up to 25 years. Achieving effective commissurotomy is key for optimal results after successful PMC.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Valvular Heart Disease

Background:

  • Late prognosis after percutaneous mitral commissurotomy (PMC) remains unclear.
  • A randomized trial compared long-term outcomes of Inoue versus double-balloon PMC techniques up to 25 years.

Purpose of the Study:

  • To compare the late clinical results of two percutaneous mitral commissurotomy (PMC) techniques.
  • To evaluate event-free survival and identify predictors of clinical events after successful PMC.

Main Methods:

  • A randomized trial involving 302 patients with severe mitral stenosis.
  • Patients were assigned to Inoue (n=152) or double-balloon (n=150) PMC.
  • Primary end point was a composite of death, mitral surgery, repeat PMC, or NYHA class ≥3 deterioration.

Main Results:

  • Median follow-up was 20.7 years (maximum 25.6 years).
  • Event-free survival at 24 years was similar: 40.8% for Inoue vs. 42.6% for double-balloon (HR 0.88, P=.423).
  • Absence of post-PMC commissural mitral regurgitation and immediate post-PMC mitral valve area <1.8 cm² independently predicted clinical events.

Conclusions:

  • Both Inoue and double-balloon PMC methods demonstrate similar favorable long-term clinical outcomes.
  • Optimizing late results of PMC depends on achieving effective commissurotomy, indicated by post-PMC commissural MR or an immediate post-PMC MVA ≥1.8 cm².

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
316
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
391
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
694
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
642